EE03518B1 - Farmatseutiline kompositsioon ja selle kasutamine - Google Patents

Farmatseutiline kompositsioon ja selle kasutamine

Info

Publication number
EE03518B1
EE03518B1 EE9800134A EE9800134A EE03518B1 EE 03518 B1 EE03518 B1 EE 03518B1 EE 9800134 A EE9800134 A EE 9800134A EE 9800134 A EE9800134 A EE 9800134A EE 03518 B1 EE03518 B1 EE 03518B1
Authority
EE
Estonia
Prior art keywords
pharmaceutical composition
composition
tonicity
alkyloxy
arylalkyl
Prior art date
Application number
EE9800134A
Other languages
English (en)
Estonian (et)
Other versions
EE9800134A (et
Inventor
M. Gelotte Karl
Original Assignee
Merck & Co., Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9603721.3A external-priority patent/GB9603721D0/en
Application filed by Merck & Co., Inc. filed Critical Merck & Co., Inc.
Publication of EE9800134A publication Critical patent/EE9800134A/xx
Publication of EE03518B1 publication Critical patent/EE03518B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4465—Non condensed piperidines, e.g. piperocaine only substituted in position 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EE9800134A 1995-10-27 1996-10-23 Farmatseutiline kompositsioon ja selle kasutamine EE03518B1 (et)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US590795P 1995-10-27 1995-10-27
GBGB9603721.3A GB9603721D0 (en) 1996-02-22 1996-02-22 Composition for inhibiting platelet aggregation
PCT/US1996/017193 WO1997015328A1 (en) 1995-10-27 1996-10-23 Pharmaceutical compositions containing platelet aggregation inhibitors

Publications (2)

Publication Number Publication Date
EE9800134A EE9800134A (et) 1998-10-15
EE03518B1 true EE03518B1 (et) 2001-10-15

Family

ID=26308777

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800134A EE03518B1 (et) 1995-10-27 1996-10-23 Farmatseutiline kompositsioon ja selle kasutamine

Country Status (34)

Country Link
EP (1) EP0859634B1 (cs)
JP (1) JP3452367B2 (cs)
KR (1) KR100362799B1 (cs)
CN (1) CN1158107C (cs)
AT (1) ATE213648T1 (cs)
AU (1) AU712755B2 (cs)
BG (1) BG63623B1 (cs)
BR (1) BR9610878A (cs)
CA (1) CA2234364C (cs)
CO (1) CO4770960A1 (cs)
CY (1) CY2292B1 (cs)
CZ (1) CZ290381B6 (cs)
DE (1) DE69619540T2 (cs)
DK (1) DK0859634T3 (cs)
DZ (1) DZ2110A1 (cs)
EA (1) EA000628B1 (cs)
EE (1) EE03518B1 (cs)
ES (1) ES2171749T3 (cs)
HU (1) HU228757B1 (cs)
IL (1) IL123790A (cs)
IS (1) IS1948B (cs)
MX (1) MX9803275A (cs)
MY (1) MY116837A (cs)
NO (1) NO324415B1 (cs)
NZ (1) NZ323134A (cs)
PL (1) PL185744B1 (cs)
PT (1) PT859634E (cs)
SA (1) SA96170527B1 (cs)
SI (1) SI0859634T1 (cs)
SK (1) SK282353B6 (cs)
TR (1) TR199800716T2 (cs)
TW (1) TW385248B (cs)
UA (1) UA45423C2 (cs)
WO (1) WO1997015328A1 (cs)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ633900A0 (en) 2000-03-20 2000-04-15 Jurox Pty Ltd Anaesthetic composition
CN1322863C (zh) * 2004-10-29 2007-06-27 武汉远大制药集团股份有限公司 一种抑制血小板凝聚的注射液及其制备方法
CN100386079C (zh) * 2005-03-24 2008-05-07 武汉远大制药集团股份有限公司 一种抑制血小板凝聚的注射用粉针及其制备方法
CN100367961C (zh) * 2005-09-30 2008-02-13 天津南开允公医药科技有限公司 盐酸替罗非班冻干粉针注射剂及其制备方法
CN102125519B (zh) * 2011-02-28 2012-07-11 正大青春宝药业有限公司 稳定的盐酸替罗非班注射液及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4931441A (en) * 1988-11-09 1990-06-05 Luitpold Pharmaceuticals, Inc. Stabilized aqueous leucovorin calcium compositions
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
CA2234364C (en) 2000-02-08
JPH10512296A (ja) 1998-11-24
SA96170527B1 (ar) 2005-12-21
CN1158107C (zh) 2004-07-21
SK282353B6 (sk) 2002-01-07
CZ290381B6 (cs) 2002-07-17
HK1017846A1 (en) 1999-12-03
CZ127898A3 (cs) 1998-10-14
MX9803275A (es) 1998-09-30
EA199800336A1 (ru) 1998-10-29
CN1200676A (zh) 1998-12-02
BR9610878A (pt) 1999-07-13
UA45423C2 (uk) 2002-04-15
CY2292B1 (en) 2003-07-04
NO324415B1 (no) 2007-10-08
HUP9902521A2 (hu) 1999-12-28
JP3452367B2 (ja) 2003-09-29
NO981869D0 (no) 1998-04-24
DK0859634T3 (da) 2002-03-25
HUP9902521A3 (en) 2000-01-28
EP0859634B1 (en) 2002-02-27
PL326419A1 (en) 1998-09-14
SK51298A3 (en) 1998-12-02
TW385248B (en) 2000-03-21
DE69619540T2 (de) 2002-08-22
TR199800716T2 (xx) 1998-07-21
IL123790A (en) 2001-11-25
EE9800134A (et) 1998-10-15
EP0859634A1 (en) 1998-08-26
ATE213648T1 (de) 2002-03-15
EA000628B1 (ru) 1999-12-29
MY116837A (en) 2004-04-30
DE69619540D1 (de) 2002-04-04
SI0859634T1 (en) 2002-04-30
IS1948B (is) 2004-10-13
IL123790A0 (en) 1998-10-30
KR100362799B1 (ko) 2003-07-16
AU712755B2 (en) 1999-11-18
AU7718996A (en) 1997-05-15
PL185744B1 (pl) 2003-07-31
ES2171749T3 (es) 2002-09-16
HU228757B1 (en) 2013-05-28
IS4699A (is) 1998-03-24
BG63623B1 (bg) 2002-07-31
WO1997015328A1 (en) 1997-05-01
NO981869L (no) 1998-04-24
BG102405A (en) 1999-08-31
CO4770960A1 (es) 1999-04-30
NZ323134A (en) 1999-11-29
PT859634E (pt) 2002-07-31
KR19990067020A (ko) 1999-08-16
DZ2110A1 (fr) 2002-07-22
CA2234364A1 (en) 1997-05-01

Similar Documents

Publication Publication Date Title
NO963053D0 (no) Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav
DE69328192D1 (de) Injizierbare Arzneizubereitungen enthaltend Taxanderivate
GB1520197A (en) Stable antibiotic compositions
DE19875032I2 (de) Mometason-Furoate-Monohydrat, Verfahren zu seiner Herstellung und das enthaltende pharmazeutische Zusammensetzungen
YU13695A (sh) Upotreba 2-fenil-3-aroilbenzotiofena i njihove farmaceutske formulacije
RU93005057A (ru) Фармацевтические соединения, производные тиенобензодиазепина, способ их получения, фармкомпозиция и их использование
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
LV10949A (lv) Aizvietoti 4-fenil-4piperidinkarboksamidi to iegusanas panemiens farmaceitiska kompozicija
MY117090A (en) Substituted benzamidines, their preparation and their use as pharmaceutical compounds
KR960007592A (ko) 신규한 피롤로카바졸
EA199801028A1 (ru) Применение производных п-аминофенола для проготовления фармацевтических композиций, используемых при лечении нейродегенеративных заболеваний
KR890011596A (ko) 불면증 치료용 의약품의 제조에 있어서 1,4-이치환-피페리디닐 화합물의 용도
RU94044438A (ru) Применение 2-фенил-3-ароилбензтиофенов для подавления способности к зачатию у женщин
KR880000413A (ko) 항알레르기 및 소염 제제와 그의 제조방법
KR890014480A (ko) 2-피리딜아세트산 유도체, 이의 제조방법 및 이를 함유하는 약제학적 조성물
EE03518B1 (et) Farmatseutiline kompositsioon ja selle kasutamine
YU5893A (sh) Sulfonilkarbamid i postupak za njegovo dobijanje
DE69132578D1 (de) Cephemderivate
ATE81775T1 (de) Pharmazeutische zusammensetzungen.
IE832680L (en) Nitrosourea derivatives.
HUP9802736A2 (hu) 1,4-Dihidropiridin-származékok alkalmazása artériafal ateroszklerózisos degradálódásának megelőzésére és gyógyítására alkalmas gyógyszerkészítmény előállítására
KR940018351A (ko) 노나테트라에노산 유도체
IL71068A (en) N-(3-trifluoromethylphenyl)-n'-propargyl-piperazine,its preparation and pharmaceutical compositions containing it
FI860098A0 (fi) Nya piperazinderivat, foerfarande foer deras framstaellning och farmaceutiska kompositioner som innehaoller dessa foereningar som aktiv ingrediens.
GB1549074A (en) Oral compositions containing trifluoromethyl phenyl bis-biguanides as antiplaque agents

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

KB4A Valid patent at the end of a year

Effective date: 20041231

KB4A Valid patent at the end of a year

Effective date: 20051231

KB4A Valid patent at the end of a year

Effective date: 20061231

KB4A Valid patent at the end of a year

Effective date: 20071231

KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20091231

KB4A Valid patent at the end of a year

Effective date: 20101231

GB1A Change in the ownership or in the address of the owner
MM4A Lapsed by not paying the annual fees

Effective date: 20141023